ASX:AC8 AusCann Group (AC8) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About AusCann Group Stock (ASX:AC8) 30 days 90 days 365 days Advanced Chart Remove Ads Get AusCann Group alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume537,446 shsAverage VolumeN/AMarket Capitalization$17.62 millionP/E RatioN/ADividend Yield6.79%Price TargetN/AConsensus RatingN/A Company OverviewAusCann Group Holdings Ltd engages in the development and commercialization of cannabinoid-derived therapeutic products for humans and animals in Australia and internationally. Its principal product includes the novel tetrahydrocannabinol and cannabidiol (THC/CBD), a powder-based hard-shell capsules based on AusCann's Neuvis platform for the treatment of pain and related indications. The company is also involved in the research and development of medicinal cannabis. It offers its products to healthcare professionals and veterinarians. AusCann Group Holdings Ltd is based in West Perth, Australia.Read More… Remove Ads Receive AC8 Stock News and Ratings via Email Sign-up to receive the latest news and ratings for AusCann Group and its competitors with MarketBeat's FREE daily newsletter. Email Address AC8 Stock News HeadlinesAusCann Group Holdings Ltd (ACNNF)August 23, 2024 | finance.yahoo.comPro Tips For Using The AC-8 Autocannon In Helldivers 2April 28, 2024 | msn.comUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 40-year career. During the presentation, Larry reveals a strategy every trader and investor needs to understand. He calls it “Bitcoin Skimming.”March 26, 2025 | Brownstone Research (Ad)AusCann Group Holdings Stock (OTC:ACNNF) Dividends: History, Yield and DatesJanuary 1, 2024 | benzinga.comAC8.AX - AusCann Group Holdings LtdJune 2, 2023 | finance.yahoo.comAussie pot stock update: Here’s what you missed this monthMay 5, 2023 | fool.com.auHere are 3 recent IPOs every investor should know aboutApril 26, 2023 | fool.com.auACNNF AusCann Group Holdings LtdMarch 28, 2023 | seekingalpha.comSee More Headlines AC8 Stock Analysis - Frequently Asked Questions What other stocks do shareholders of AusCann Group own? Based on aggregate information from My MarketBeat watchlists, some other companies that AusCann Group investors own include 3D Systems (DDD), Bristol-Myers Squibb (BMY), Johnson & Johnson (JNJ), Workday (WDAY), Zoom Video Communications (ZM), Zynerba Pharmaceuticals (ZYNE) and Ambarella (AMBA). Industry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolASX:AC8 CIKN/A Webwww.auscann.com.au Phone61 0 9561 8834FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)A($0.06) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-9,440,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-1.09% Return on Assets-1.67% Debt Debt-to-Equity RatioN/A Current Ratio33.22 Quick Ratio20.17 Sales & Book Value Annual Sales$1.36 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow2.05 Book ValueA$0.01 per share Price / BookN/AMiscellaneous Outstanding Shares440,550,000Free FloatN/AMarket Cap$17.62 million OptionableNot Optionable Beta0.72 A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for April 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free Report This page (ASX:AC8) was last updated on 3/26/2025 by MarketBeat.com Staff From Our PartnersTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredDOGE could send 6 AI stocks through the roofStay alert for Elon Musk and the Department of Government Efficiency's next move … Expect an announcement f...Weiss Ratings | SponsoredTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredNvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry."If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...Brownstone Research | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredThis Crypto Is Set to Explode in FebruaryBryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AusCann Group Holdings Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Share AusCann Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
